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Bacteria of the genus Frankia are mycelium-forming actinomycetes that are found as nitrogen-fixing facul-
tative symbionts of actinorhizal plants. Although soil-dwelling actinomycetes are well-known producers of
bioactive compounds, the genus Frankia has largely gone uninvestigated for this potential. Bioinformatic
analysis of the genome sequences of Frankia strains ACN14a, CcI3, and EAN1pec revealed an unexpected
number of secondary metabolic biosynthesis gene clusters. Our analysis led to the identification of at least 65
biosynthetic gene clusters, the vast majority of which appear to be unique and for which products have not been
observed or characterized. More than 25 secondary metabolite structures or structure fragments were pre-
dicted, and these are expected to include cyclic peptides, siderophores, pigments, signaling molecules, and
specialized lipids. Outside the hopanoid gene locus, no cluster could be convincingly demonstrated to be
responsible for the few secondary metabolites previously isolated from other Frankia strains. Few clusters were
shared among the three species, demonstrating species-specific biosynthetic diversity. Proteomic analysis of
Frankia sp. strains CcI3 and EAN1pec showed that significant and diverse secondary metabolic activity was
expressed in laboratory cultures. In addition, several prominent signals in the mass range of peptide natural
products were observed in Frankia sp. CcI3 by intact-cell matrix-assisted laser desorption-ionization mass
spectrometry (MALDI-MS). This work supports the value of bioinformatic investigation in natural products
biosynthesis using genomic information and presents a clear roadmap for natural products discovery in the
Frankia genus.
The large bacterial phylum Actinobacteria harbors a diverse
assemblage of high-GC, Gram-positive bacteria that prosper
in a wide range of environments (60). A notable feature of the
microbes belonging to the order Actinomycetales is their met-
abolic versatility in the production of chemically diverse and
biologically potent natural products (10). Genomic analyses
have clarified the extent of their secondary metabolic profi-
ciency, which is particularly wide ranging in those with genome
sizes greater than 5 Mb (39). As exemplified by the genus
Streptomyces, many soil-dwelling, filamentous actinomycetes
are prolific natural product producers, secreting antimicrobial
agents, signaling molecules, pigments, and other chemicals into
their surroundings to thwart competition or condition their
environment (17). While biosynthetic pathways to secondary
metabolites are numerous and diverse, advances in the molec-
ular rationale behind natural product assembly have allowed
for the prediction of chemical classes and structures (15).
Frankia bacteria are mycelium-forming actinomycetes that
are found as nitrogen-fixing symbionts in the root nodules of
angiosperm plant species but can also survive as free-living soil
bacteria (9, 14). These bacteria are developmentally complex,
forming three cell types: vegetative hyphae, spores located in
sporangia, and unique lipid-enveloped cellular structures
called vesicles. Vesicles are formed inside the plant cells of the
nodules or in culture under nitrogen-limiting conditions and
act as specialized structures for nitrogen fixation process.
These slow-growing microbes inhabit highly selective environ-
ments and are often closely associated with actinorhizal plant
families with distinct host ranges. Genome sequence analysis
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of three strains with different host range specificities revealed
large genomic variance in which genome size markedly ex-
panded upon host plant diversification (40). Sizes varied from
5.43 Mb for the narrow-host-range Frankia strain CcI3 to 7.50
Mb for the medium-host-range Frankia strain ACN14a (ACN)
to 8.98 Mb for the broad-host-range Frankia strain EAN1pec
(EAN). Since the elucidation of these Frankia genomes, bioin-
formatic approaches have illuminated codon usage patterns
(47), predicted secretosome profiles (35), and led to genome-
guided studies on the Frankia transcriptome (3, 44) and pro-
teome (1, 5, 33, 34). Genome mining also provides an oppor-
tunity to identify important physiology and metabolic
functions, including secondary metabolism. This approach
helped identify the auxin biosynthesis pathway used by
Frankia strain CcI3 to drive nodule development in Casu-
arina glauca (41).
Beyond a few cases, Frankia natural product biochemistry
has largely been unexplored and is ripe for genome-mining
approaches. Quinonoid pigments of presumptive polyketide
origin and a derivative of the calcium-binding streptomycete-
produced calcimycin antibiotics, demethyl C-11 cezomycin,
were isolated from Frankia strains ORS 020604 and AiPs1,
respectively, and their structures determined as early examples
of Frankia-based natural products (25, 30). The most well-
studied area for Frankia has focused on the production of
numerous oxidized and cyclopropanated fatty acids and triter-
pene hopanoids that differ in content between vegetative-
growth cells and those in N2-fixing vesicles (54). Hopanoids are
a major component of the vesicle cell envelope and serve to
protect nitrogenase from oxygen inactivation (11). Experi-
ments with various Frankia cultures have furthermore indi-
cated production of compounds with siderophore and antibi-
otic activities, though novel structures have not been reported
(24). Discovery work using Frankia cultures is hampered by
their slow growth and difficult laboratory manipulation (7).
Hence, bioinformatics offers a glimpse into the Frankia sec-
ondary metabolome that may provide new insights into their
relationships with higher plants. The goal of this study was to
reveal the predicted Frankia secondary metabolome, including
potential structures, and to show proof of concept for this
approach. These predicted natural products would provide
potential targets for future studies on plant-microbe interac-
tions and other functions involved in Frankia physiology.
MATERIALS AND METHODS
Bioinformatic analysis. Biosynthetic loci in Frankia strains ACN14a
(GenBank accession no. CT573213.2), CcI3 (GenBank accession no.
CP000249.1), and EAN1pec (GenBank accession no. CP000820.1) were identi-
fied using a BLAST-based method previously reported (55). Briefly, translated
genes from each Frankia genome were compared to a collection of 20 “standard”
secondary metabolism gene or domain sequences using the BLASTp algorithm.
High local concentrations of hits (genes with a BLASTp error value less than
E07), as well as indicative single-target hits, were grouped with approximately
10 kb of nucleotide sequence upstream and downstream and labeled as putative
biosynthetic gene clusters. Putative clusters were given species-specific designa-
tions (FA, Frankia strain ACN14a; FC, Frankia strain CcI3; and FE, Frankia
strain EAN1pec). Further analysis of the clusters led to elimination of false
secondary metabolism hits, leading to minor gaps in numbering. Open reading
frames (ORFs) were verified using FramePlot (27). BLAST (4), CD-Search (32),
and Pfam (8) were used for sequence analysis and prediction of gene functions,
and Gene Neighborhood (36) and KEGG (29) were utilized for comparative
analysis. Natural product-specific analysis methods (55) were used for determi-
nation of polyketide synthase (PKS) ketosynthase loading versus extension ca-
pability, acyltransferase substrate specificity, ketoreductase stereochemistry,
nonribosomal peptide synthetase (NRPS) adenylation domain amino acid spec-
ificity, and condensation domain cyclization capability. As clear guidelines for the
delineation of biosynthetic gene cluster boundaries do not exist, best estimates
were made on the basis of functional analysis, GC or codon bias, substantial
(1-kb) gaps between ORFs, and/or the presence of transposition-associated
genes and genes of unknown/unpredictable function.
Culture conditions. Frankia strains EAN1pec and CcI3 were grown and main-
tained in succinate and propionate growth medium, respectively, with NH4Cl as
the nitrogen source, as described previously (52). Under N2 conditions, cultures
were grown in their respective growth media without NH4Cl. For the 15N label-
ing experiments, CcI3 cultures were grown 7 days in propionate growth medium
containing 10 mM 15NH4Cl (100% 15N).
Proteomic analysis. Frozen pellets of EAN and CcI3 were resuspended in 100
mM Tris-HCl (pH 7.5) and sonicated. The crude lysate was centrifuged and the
supernatant collected. Ammonium sulfate-precipitated proteins were resus-
pended in Tris-HCl, quantified by a Bradford assay (B6919; Sigma-Aldrich), and
digested overnight (trypsin singles kit; Sigma-Aldrich). Mass spectrometry anal-
ysis was performed with an Agilent 1200 quaternary pump high-performance
liquid chromatograph (HPLC) fitted with an in-house reversed-phase C18
100-m by 5-m fused silica capillary column and coupled with a Thermo
Scientific LTQ XL mass spectrometer. The data were searched against the CcI3
(GenBank accession no. CP000249.1) and EAN (GenBank accession no.
CP000820.1) genomes and a database of common contaminants (such as human
keratin and porcine trypsin).
Intact-cell (IC) MALDI-TOF analysis. Regular and 15N incubated cultures of
Frankia sp. CcI3 were prepared as described above and frozen samples spun
down in 1.5-ml Eppendorf tubes for 1 min at 10,000 rpm. Approximately 1 l of
each pellet was placed on a well of the matrix-assisted laser desorption ionization
(MALDI) target plate (Bruker Microflex MSP 96 stainless steel target) and
analyzed by MALDI-time of flight (TOF) mass spectrometry as previously de-
scribed (20).
RESULTS AND DISCUSSION
Organization and general features of the Frankia secondary
metabolome. The sequenced Frankia strains maintain no plas-
mids, have similar numbers of protein-coding regions per ki-
lobase (CcI3, 0.829; ACN, 0.905; and EAN, 0.882), and, de-
spite the vast differences in chromosome size, appear very
closely related on the basis of 16S rRNA sequence identity
(each 98 to 99% identical to the other) (40). In total, 65
secondary metabolism biosynthetic gene clusters from the
Frankia genomic sequences were identified (Fig. 1). Of these,
more than half were clusters for which chemical structure
predictions of all or part of the products could be made by
bioinformatic analysis alone. With the exception of the ex-
pected hopanoid-related biosynthetic genes (2, 18), no clusters
could be unambiguously correlated with any of the few known
secondary metabolites isolated from Frankia strains, and none
of the Frankia modular PKS- or NRPS-containing gene clus-
ters have previously been identified in other species. Despite
the wide variability of chromosome sizes, clusters were evenly
distributed between the strains, with roughly 20 found in each.
Thus, at least in the case of the Frankia genomes available,
genome size was not a predictor of biosynthetic potential (19).
Brief descriptions and chromosomal locations of secondary
metabolic gene clusters are cataloged in Table 1 and Fig. 1,
respectively.
Presumed nonfunctional, fragmented biosynthetic clusters,
such as those reported to occur at the unstable ends of Strep-
tomyces coelicolor A3(2) and S. avermitilis linear chromosomes
(39), were observed only in the smallest (for CcI3: FC01, FC03,
FC13, and FC15b) and largest (for EAN: FE11, FE16, and
FE23) chromosomes. Assumptions of nonfunctionality were
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made on a variety of bases, most typically including lack of
critical fragments of domains or active site residues. Although
genome sequencing assembly issues should not be ruled out, it
is possible that the presence of fragmented clusters are an
artifact following the presumed expansion of the EAN chro-
mosome or a possible contraction in the case of the CcI3
chromosome (40). Highlights of our findings are described
below.
Gene clusters associated with polyketide biosynthesis. Bio-
synthetic gene clusters associated with polyketide-derived spe-
cialized lipids are a predominant theme in the putative Frankia
secondary metabolome. Previous lipid studies revealed that
Frankia N2-fixing vesicles are replete with unknown long-chain
polyhydroxy fatty acids as well as typical iso-branched and
monounsaturated fatty acids (54). Many iterative PKS systems
were observed in each genome, several containing genes with
strong similarity to mycobacterial PKSs associated with the
synthesis of mycocerosates (53) (FA02, FA11, and FE22; com-
pound 1) (Fig. 2). Novel biosynthetic routes to similar mole-
cules also exist, such as the type I modular PKSs in clusters
FA01, FE18, and FE21, whose repetitive domain structures
imply construction of more highly oxidized, differentially meth-
ylated analogs of mycocerosates (such as compounds 2, 3, and
4). These results indicate chemical similarities between the
composition of the cell walls of the disease-causing mycobac-
teria (16, 23) and the plant symbiont Frankia. PKSs from clus-
ters FA04, FC15a, and FE17 bear strong architectural similar-
ity to polyunsaturated fatty acid (PUFA) biosynthetic systems
from marine gammaproteobacteria (37), which may represent
novel PUFA biochemistry in a terrestrial bacterium. While
genes encoding acetyl-coenzyme A (CoA) carboxylase systems
are also observed clustered in the Frankia PUFA PKSs, they
are uniquely flanked by a number of genes suggestive of lipid
metabolism. Thus, the Frankia clusters may code for the syn-
thesis of modified PUFA products (compound 5).
The Frankia bacteria also contain antibiotic-like modular
type I PKSs (e.g., FA17 and FE12), nonreducing iterative type
I PKSs (e.g., FE20; compound 6), heterodimeric type II PKSs
associated with spore pigment (FA20, FC14, and FE03) and
antibiotic (FC17) production, and homodimeric type III PKSs
(FA24 and FE15) (Table 1). The FA17 and FE12 gene clusters
encode large, modular type I PKS systems lacking typical ter-
minal offloading thioesterase (TE) domains. Flanking the five
PKS open reading frames of FA17 are genes homologous to
chlM and chlD1-4 from the Streptomyces antibioticus chloro-
thricin biosynthetic gene cluster (28). Taken together, these
data suggest that FA17 codes for the biosynthesis of a novel
spirotetronate antibiotic (50) such as compound 7 with pro-
grammed differences in the PKS-derived region. The FE12
locus rather harbors a smaller tetramodular PKS that appears
to be primed with 3-amino-5-hydroxybenzoic acid (AHBA),
characteristic of ansamycin polyketide antibiotics such as rifa-
mycin (21). Genes encoding AHBA biosynthetic enzymes
are not entirely contained in the FE12 locus but partially
reside elsewhere in the genome in a conserved region
(Franean1_1658 to -1664) common with CcI3 and ACN.
FE12-associated polyketide extension with four methylmalo-
nyl-CoA molecules followed by macrolactam and cyclic ether
formation of the highly functionalized polyketide chain may
yield the recently described Saccharopolyspora cebuensis mac-
rolactams cebulactams A1 and A2 (compound 8), for which no
biosynthetic studies have been reported (43).
Gene clusters associated with nonribosomal peptide biosyn-
thesis. All three Frankia genomes maintain nonribosomal pep-
tide synthetases (NRPSs) for siderophores and antibiotic-like
cyclic peptides (31). Three Frankia NRPS-based siderophore
biosynthetic pathways (FA19, FE01, and FE07) are expected
to produce molecules containing iron-chelating residues such
as phenols/catechols, oxazolines/thiazolines, and hydroxam-
ates. In each case, the NRPS domain architecture suggests the
sequential addition of salicylate or 2,3-dihydroxybenzoate fol-
lowed by serine or cysteine and a further 3 to 6 amino acid
residues to give compound 9 (FA19), compound 10 (FE01),
and compound 11 (FE07). All three Frankia genomes harbor a
FIG. 1. Circular chromosomes of Frankia sp. HFPCcI3 (CCI), Frankia sp. ACN14a (ACN), and Frankia sp. EAN1pec (EAN), oriented to the
dnaA gene. The inner ring indicates deviation of GC content from the genomic average. The outside outer ring shows the locations of secondary
metabolic gene clusters that correlate with the cluster names provided in Table 1.
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homologous eight-gene NRPS-independent siderophore (6)
biosynthetic locus (FA23, FC24, and FE06) for the assembly of
an aerobactin-like siderophore. The Frankia genomes also
carry isolated NRPS-encoding genes such as in FA05, FC05,
and FE04 that may be involved in the biosynthesis of small
quinone metabolites (compound 12).
CcI3 and ACN contain giant NRPS gene clusters (FC12 and
FA08) associated with the biosynthesis of cyclic peptides. Clus-
TABLE 1. Distribution, biosynthetic classification, and predicted products of the secondary metabolome of
Frankia strains ACN14a, CcI3, and EANpec1
Strain and gene
cluster Approximate location Type Proposed product
Predicted
structurea
Frankia alni ACN14a
FA01 FRAAL0341–FRAAL0352 Type I modular PKS Specialized lipid 2
FA02 FRAAL1275–FRAAL1282 Type I PKS Mycocerosate-like lipids 1
FA03 FRAAL1549–FRAAL1558 Type I iterative PKS Unknown Unk
FA04 FRAAL1658–FRAAL1682 Type I iterative PKS PUFA 5
FA05 FRAAL1880 Quinone “NRPS” Unknown quinones 12
FA08 FRAAL2558–FRAAL2576 Hybrid PKS-NRPS Hybrid polyketide/peptide 14
FA10 FRAAL2909–FRAAL2914 Type I iterative PKS Unknown, same as FA03 Unk
FA11 FRAAL2986–FRAAL2992 Type I PKS Mycocerosate-like lipids 1
FA12 FRAAL3193–FRAAL3198 Type I iterative PKS PUFA 5
FA14 FRAAL3421–FRAAL3473 Type I PKS Beta-hydroxy butyrate Unk
FA17 FRAAL4060–FRAAL4102 Type I PKS Chlorothricin-like ring system 7
FA18 FRAAL4105 Quinone “NRPS” Unknown quinones 12
FA19 FRAAL4152–FRAAL4172 NRPS Siderophore 9
FA20 FRAAL4378–FRAAL4406 Type II PKS Spore pigment Unk
FA23 FRAAL6421–FRAAL6428 Non-NRPS siderophore Siderophore, same as FC24, FE06 Unk
FA24 FRAAL6457–FRAAL6460 Type III PKS Unknown, see also FE15 Unk
FA25 FRAAL2154–FRAAL2174 Terpene synthase Carotenoids 20
FA26 FRAAL1427–FRAAL1449 Terpene synthase Hopanoids 15-19
FA27 FRAAL1335–FRAAL1339 Terpene cyclase Pentalenene 22
FA28 FRAAL6507 Terpene cyclase Geosmin 21
FA29 FRAAL6371–FRAAL6381 Phosphonate Unknown Unk
FA30 FRAAL4919–FRAAL4922 Ribosomal peptide Microcin-like Unk
FA31 FRAAL4634–FRAAL4646 Aminocyclitol Cetoniacytone-like Unk
Frankia sp. CcI3
FC01 Francci3_365 NRPS (PCP-TE didomain) Fragmented/nonproducing cluster? Unk
FC02 Francci3_0926–Francci3_0931 Type I iterative PKS Unknown, same as FA03 Unk
FC03 Francci3_0987–Francci3_1000 Type I iterative PKS Halogenated lipid Unk
FC04 Francci3_1111–Francci3_1120 PKS Fragmented/nonproducing cluster? Unk
FC05 Francci3_1178 Quinone “NRPS” Unknown quinones 12
FC07 Francci3_1926–Francci3_1934 FAS/PKS Cyclopropanated lipids Unk
FC08 Francci3_1967–Francci3_1993 Hybrid PKS-NRPS Modified glycine Unk
FC11 Francci3_2406 Quinone “NRPS” Unknown quinones 12
FC12 Francci3_2442–Francci3_2466 NRPS Potential antibiotic 13
FC13 Francci3_2596 PKS (KS domain) Fragmented/nonproducing cluster? Unk
FC14 Francci3_2845–Francci3_2867 Type II PKS Spore pigment, same as FA20 Unk
FC15a Francci3_2921–Francci3_2941 Type I iterative PKS PUFA 5
FC15b Francci3_2981–Francci3_2987 Type I PKS Fragmented/nonproducing cluster? Unk
FC17 Francci3_4095–Francci3_4107 Type II PKS Octaketide antiobiotic Unk
FC18 Francci3_4124–Francci3_4155 Incomplete type II PKS None? Or tailoring for FC17? Unk
FC19 Francci3_4231 Terpene cyclase Geosmin 21
FC20 Francci3_4330–Francci3_4335 Terpene cyclase Oxidized pentalenene 22
FC22 Francci3_1383–Francci3_1398 Terpene synthase Carotenoids, same as FA25 20
FC23 Francci3_818–Francci3_834 Terpene synthase Hopanoids 15-19
FC24 Francci3_4054–Francci3_4061 Non-NRPS siderophore Siderophore, same as FA23, FE06 Unk
FC25 Francci3_2983–Francci3_2987 Ribosomal peptide Microcin-like Unk
FC26 Francci3_4195–Francci3_4202 Thiopeptide Thiocillin-like Unk
Frankia sp. EAN1pec
FE01 Franean1_3052–Franean1_3065 NRPS Tetrapeptide siderophore 10
FE03 Franean1_2387–Franean1_2400 Type II PKS Spore pigment, same as FA20 Unk
FE04 Franean1_1665 Quinone “NRPS” Unknown quinones 12
FE06 Franean1_655–Franean1_662 Non-NRPS siderophore Siderophore, same as FA23, FC24 Unk
FE07 Franean1_5933–Franean1_5952 NRPS Hexapeptide siderophore 11
FE08 Franean1_5774–Franean1_5780 Type I PKS Unknown Unk
FE09 Franean1_5610–Franean1_5615 Type I iterative PKS Unknown, same as FA03 Unk
FE10 Franean1_5559 Terpene cyclase Geosmin 21
FE11 Franean1_5372–Franean1_5375 PKS (KS domain) Fragmented cluster? Unk
FE12 Franean1_4821–Franean1_4849 Type I PKS Polyketide with AHBA starter 8
FE15 Franean1_4393–Franean1_4396 Type III PKS Unknown, see also FA24 Unk
FE16 Franean1_4260–Franean1_4280 Type I PKS Fragmented/nonproducing cluster? Unk
FE17 Franean1_5590–Franean1_5618 Type I iterative PKS PUFA 5
FE18 Franean1_3882–Franean1_3902 Type I modular PKS Specialized lipid 3
FE20 Franean1_3607–Franean1_3623 Type I iterative PKS Aromatic compound 6
FE21 Franean1_3454–Franean1_3497 Type I PKS Specialized lipid 4
FE22 Franean1_3355–Franean1_3370 Type I PKS Mycocerosate-like lipids 1
FE23 Franean1_3077–Franean1_3091 Type I PKS Fragmented/nonproducing cluster? Unk
FE24 Franean1_5691–Franean1_5718 Terpene synthase Hopanoids 15-19
FE25 Franean1_5118–Franean1_5132 Terpene synthase Carotenoids, same as FA25 20
a Numbers correspond to predicted structures shown in Fig. 2. Unk, unknown.
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ter FC12 is expected to produce a unique, halogenated tride-
capeptide (compound 13), which may have antibacterial prop-
erties based upon its predicted structural resemblance to
existing antibiotics of the vancomycin group (26). In addition
to the large, 13-module NRPS system, we identified gene cas-
settes involved in the biosynthesis of the vancomycin-contain-
ing nonproteinogenic amino acids 4-hydroxyphenylglycine and
3,5-dihydroxyphenylglycine. While many of the FC12 gene
products, including a flavin adenine dinucleotide (FAD)-de-
pendent halogenase that putatively chlorinates phenol resi-
dues, resemble those of the vancomycin/teichoplanin class of
antibiotics, the cytochrome P450 coupling enzymes that are
required for the cross-coupling of vancomycin’s aromatic rings
are absent (57). As a consequence, the product of FC12 (com-
FIG. 2. Putative Frankia chemical structures based on bioinformatic analysis of Frankia biosynthetic gene clusters. Compound numbers
correlate with the “Predicted structure” data in Table 1.
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pound 13) is predicted to resemble cyclic peptide antibiotics
related to ramoplanin A2 and enduracidin (59). Cluster FA08
codes for the biosynthesis of a hybrid PKS/NRPS-derived mol-
ecule (compound 14) related in chemical structure to the
polyoxypeptin family of potent apoptosis-inducing N-acyl cyclic
hexadepsipeptides (56).
Gene clusters associated with terpenoid biosynthesis. Ho-
panoids are important lipid components of the Frankia vesicle
envelope, where they account for up to 87% of the total lipids
(11, 38). Predominant Frankia hopanoids identified in CcI3
and other strains include bacteriohopanetetrols (compounds
15 to 17) and moretan-29-ol (compound 18), which are assem-
bled from hopene (compound 19) by squalene-hopene cyclase
(Shc) (2, 18). Their production is governed by a homologous
shc-containing gene cluster (FA26, FC23, and FE24) in the
three sequenced Frankia genomes related in structure and
organization to those in S. coelicolor A3(2), Bradyrhizobium
japonicum USDA110, and Zymomonas mobilis ZM4, which
produce related hopanoid lipids (39, 42). Conversion of bac-
teriohopanetetrol (compound 15) to its novel 35-O-phenylace-
tate monoester (compound 17) (46) may be assisted by a phe-
nylacetate-degrading enzyme derived from FA26 and FC23.
All three Frankia hopanoid gene clusters uniquely harbor a
radical S-adenosylmethionine (SAM)-dependent methyltrans-
ferase that may be involved in production of methylated de-
rivatives, which are components of the N2-fixing bacterium B.
japonicum (12) and other bacteria (45).
Sequence analysis of ACN, CcI3, and EAN also revealed
conserved terpenoid pathways to carotenoids (FA25, FC22,
and FE25) such as -carotene (compound 20) and zeaxanthin
diglucoside and the odorous terpenoid geosmin (FA28, FC19,
and FE10; compound 21), which are common streptomycete
metabolites (39). Additional terpenoid natural products may
be produced in ACN and CcI3 via FA27 and FC20, respec-
tively. These biosynthetic loci contain terpene cyclase genes
that may code for the assembly of sesquiterpenoids derived
from the tricyclic pentalenene hydrocarbon (compound 22),
which in S. avermitilis gives rise to the pentalenolactone family
of antibiotics (51). In all cases, Frankia bacteria exclusively
employ the methylerythritol phosphate pathway to the iso-
TABLE 2. Mass spectrometry of Frankia sp. EAN1pec and Frankia sp. CcI3
Species and gene cluster Gene Protein Putative protein function No. ofpeptides
No. of
spectra
%
coverage
Frankia sp. EAN1pec
FE01 Franean1_3063 158110278 Amino acid adenylation domain 1 2 0.2
FE03 Franean1_2391 158109626 Cyclase/dehydrase 2 2 26.8
Franean1_2396 158109631 Antibiotic biosynthesis monooxygenase 3 3 43.9
FE07 Franean1_5939 158113086 Periplasmic binding protein 7 16 37.6
Franean1_5945 158113092 ABC transporter related 2 2 6
FE10 Franean1_5558 158112715 Cyclic nucleotide-binding domain protein 38 154 71.9
Franean1_5559 158112716 Terpene synthase metal-binding domain protein 6 6 11.2
FE16 Franean1_4274 158111461 Isocitrate dehydrogenase NADP-dependent 24 59 35
FE17 Franean1_5592 158112747 Serine/threonine protein kinase 6 8 16.9
Franean1_5595 158112750 FHA modulated ABC efflux pump with fused ATPase
and integral membrane subunits
8 13 13.6
Franean1_5596 158112751 Hypothetical protein Franean1_5596 5 7 18
Franean1_5606 158112761 6-Phosphogluconate dehydrogenase, decarboxylating 2 2 7.6
Franean1_5616 158112770 Transcriptional regulator LuxR family 2 4 7.2
FE18 Franean1_3892 158111085 Conserved hypothetical protein 23 32 35.7
Franean1_3902 158111095 Conserved hypothetical protein 2 10 20
FE21 Franean1_3497 158110702 Superoxide dismutase 4 6 30.5
FE22 Franean1_3364 158110569 Endothelin-converting enzyme 1 2 2 3.5
FE24 Franean1_5711 158112864 Radical SAM domain protein 2 3 8.4
Franean1_5715 158112868 Amine oxidase 2 3 7.8
Franean1_5717 158112870 Squalene/phytoene synthase 2 2 6.9
Frankia sp. CcI3
FC01 Francci3_364 86565942 Hypothetical protein Francci3_0364 2 7 40
FC03 Francci3_990 86566564 3-Oxoacyl-acyl-carrier-protein synthase III 8 8 11.4
Francci3_991 86566565 Acyl transferase region 8 15 7.9
Francci3_993 86566567 FAD dependent oxidoreductase 1 2 1.3
Francci3_999 86566573 Crotonyl-CoA reductase 3 3 7
FC05 Francci3_1179 86566749 Heat shock protein Hsp20 10 27 37.4
FC08 Francci3_1985 86567550 Hypothetical protein Francci3_1985 2 3 25
FC12 Francci3_2450 86568008 Amino acid adenylation 16 22 3.2
Francci3_2452 86568010 Aminotransferase class I and II 1 2 3.4
Francci3_2454 86568012 4-Hydroxyphenylpyruvate dioxygenase 30 86 31.8
Francci3_2459 86568017 Amino acid adenylation 4 5 1.3
Francci3_2461 86568019 Amino acid adenylation 6 11 2
FC14 Francci3_2861 86568410 Enoyl-CoA hydratase 2 3 8.6
FC15a Francci3_2925 86568474 HpcH/HpaI aldolase 2 2 8.4
FC19 Francci3_4230 86569767 Cyclic nucleotide-binding domain protein 64 194 61.7
Francci3_4231 86569768 Terpene synthase, metal-binding 9 11 11.7
FC23 Francci3_833 86566408 Urease beta subunit 1 2 14.3
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prenoid building blocks isopentenyl diphosphate and its isomer
dimethylallyl diphosphate as observed in most actinomycetes
(39), although all three Frankia strains possess more than one
copy of 4-hydroxy-3-methylbut-2-enyl diphosphate reductase
(ispH) and 2-C-methyl-d-erythritol 4-phosphate cytidylyltrans-
ferase (ispD).
Other Frankia secondary metabolic pathway gene clusters.
Additional biosynthetic gene clusters are predicted for the
assembly of bacteriocin, aminocyclitol, and phosphonate nat-
ural products. Ribosomally encoded peptides related to the
Escherichia coli lasso peptide microcin J25 are predicted to
occur in ACN (FA30) and CcI3 (FC25) (48). A highly modified
thiopeptide related to the Bacillus subtilis antibiotic thiocillin
(13) is putatively produced in CcI3 (FC26). Frankia alni ACN
contains two additional biosynthetic gene clusters (FA31 and
FA29) related to cetoniacytone A, an aminocyclitol antitumor
agent from the endosymbiont Actinomyces sp. strain Lu 9419
(58), and the antibiotic and herbicidal phosphinothricin trip-
eptide from Streptomyces viridochromogenes (49). In cluster
FA29, a conserved set of six genes encodes the biosynthesis of
the phosphinothricin intermediate phosphonoformate. Addi-
tional biosynthetic genes in FA29 suggest that pathways di-
verge to give an unknown phosphonate-containing secondary
metabolite in ACN (39). Since natural phosphonates exhibit
herbicidal properties, the production of such a molecule in a
plant symbiont is an intriguing possibility.
Proteomic evidence of gene cluster expression in CcI3 and
EAN. Further insight into the gene clusters that may actively
produce natural products under laboratory culture conditions
was explored by proteomic analysis of strains EAN and CcI3.
Mass spectrometry analysis uncovered 10 candidate expressed
gene clusters in EAN that contain at least one protein hit from
at least two spectra (Table 2). Of the 10 candidates, 6 (FE03,
FE07, FE10, FE17, FE18, and FE24) had at least two protein
hits corresponding to adjacent encoding genes from each gene
set. Conversely, nine candidate expressed gene clusters were
detected in Frankia sp. CcI3, of which three (FC03, FC12, and
FC19) contained two or more protein hits with two peptide
identifications per protein. Furthermore, other transcriptome
and proteome studies show expression of some of these bio-
synthetic clusters (1, 3, 5, 33, 34, 44). These data together
indicate that Frankia has both the genetic capacity and the
biosynthetic capacity to produce secondary metabolites.
Intact-cell MALDI-TOF (IC MALDI-TOF) mass spectrom-
etry, which can be used to observe natural products from or-
ganisms with minimal work-up (20), was next employed to
probe strain CcI3. IC MALDI-TOF mass spectrometry showed
several significant signals in the mass range of NRPS-derived
secondary metabolites (Fig. 3). The ions at 1,538 and 1,554 Da
displayed a halogen isotopic signature, as the 2-Da isotopes
are larger than the monoisotopic mass and are within the
expected range of nonribosomal peptide compound 13. In ad-
dition, several ions above 1 kDa were uniquely observed in
Frankia strain CcI3. To provide further support for the pres-
ence of unique peptides, the CcI3 bacterium was grown in the
presence of 15N-labeled NH4Cl. In this case, the ions at 1,199,
1,330, 1,368, 1,538, and 1,554 Da shifted, and their isotopic
distributions broadened, indicating incorporation of 15N. The
ions at 1,538 and 1,554 Da shifted 13 Da, consistent with the
prediction that the product of FC12 is a tridecapeptide, such as
compound 13.
Summary. Our results here reveal the significant biosyn-
thetic potential of the genus Frankia in the production of novel
gene-encoded small molecules. Across the three strains exam-
ined, we found nearly all of the common classes of secondary
metabolic biosynthetic pathways. At the time of writing, eight
additional Frankia genome projects are under way: those for
Frankia strain EuI1c (GenBank accession no. CP002299),
Frankia strain EUN1f, Frankia strain QA3, Frankia strain
BCU110501, Frankia strain BMG5.12, Frankia strain CN3,
Frankia strain DC12, and the Frankia symbiont from Datisca
glomerata. On cursory examination of available data, each
shows genetic biosynthetic potential comparable to that of the
strains analyzed here. The illumination of the biosynthetic
FIG. 3. Intact-cell MALDI-TOF analysis of Frankia sp. CcI3. Top, IC MALDI revealing prominent peptides ranging from 1,199 to 1,554 Da.
Bottom, IC MALDI of Frankia sp. CcI3 grown on 15N-labeled medium depicting isotope shifts that roughly equate to the number of amino acid
residues.
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potential of Frankia should have a significant impact on the
study of host-microbe interactions. Symbiotic interactions be-
tween Frankia and its host plants are not well understood at a
molecular level. Although there are aspects common to other
plant-microbe interactions, including signaling pathways
shared between fungal and bacterial root endosymbioses in the
actinorhizal plant Casuarina and in legumes (22), the actual
signaling molecules have not been identified for the actinorhi-
zal associations. The absence of common nod genes in the
Frankia genomes indicates the use of alternative signaling mol-
ecules. The predicted structures in this study provide tempting
targets as cell signaling molecules during the establishment and
development of the symbiotic association.
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